AMP-activated protein kinase catalytic subunit alpha (AMPK alpha) (AMPK alpha)

AMP-activated protein kinase (AMPK) catalytic subunit alpha is the enzymatic component of the AMPK heterotrimer, a central regulator of cellular and whole-body energy homeostasis (Hardie et al., 2012, Nature Reviews Molecular Cell Biology). Often referred to as the 'metabolic master switch,' the alpha subunit contains the kinase domain that phosphorylates downstream targets to stimulate ATP-producing catabolic pathways while suppressing ATP-consuming anabolic processes (Herzig & Shaw, 2018, Nature Medicine). It is activated under conditions of energy stress, such as exercise or nutrient deprivation, when the AMP:ATP ratio rises, leading to phosphorylation of the alpha subunit at Threonine-172 (Oakhill et al., 2011, Science). In the context of disease, AMPK alpha is a primary therapeutic target for type 2 diabetes and metabolic syndrome due to its ability to enhance glucose uptake in skeletal muscle and inhibit gluconeogenesis in the liver (Zhang et al., 2009, Cell Metabolism). Furthermore, its role in inhibiting the mTOR pathway and regulating the cell cycle makes it a subject of intense research in oncology as a potential tumor suppressor (Faubert et al., 2015, Cell Metabolism). Pharmacological activation can occur indirectly through mitochondrial inhibition, as seen with the widely prescribed drug metformin, or directly through small molecules that bind to the Allosteric Drug and Metabolite (ADaM) site (Gowans et al., 2013, Cell Metabolism). Beyond metabolism, AMPK alpha is increasingly recognized for its roles in promoting autophagy and maintaining mitochondrial health, which are relevant for neurodegenerative and cardiovascular diseases (Garcia & Shaw, 2017, Molecular Cell). However, therapeutic targeting remains challenging due to the potential for off-target effects and the complex, context-dependent role of AMPK in different stages of cancer (Vara-Ciruelos et al., 2019, Biochemical Society Transactions).

Other names

PRKAA5'-AMP-activated protein kinase catalytic subunit alphaAMPK alpha 1AMPK alpha 2Protein kinase AMP-activated catalytic subunit alpha

Activation of the catalytic subunit via phosphorylation at Threonine-172 and allosteric binding of AMP to the gamma subunit, which protects the alpha subunit from dephosphorylation. Direct small-molecule activators bind to the Allosteric Drug and Metabolite (ADaM) site located at the interface between the alpha-catalytic and beta-regulatory subunits.